The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Scaredy, Medusa have security...
https://images.app.goo.gl/s6yo9jVt5EqheMTU7
From ABDX trading update today:
“Contract service for partners
In addition, Abingdon continues to work with contract service partners on the transfer of assays to large-scale manufacture and the Company has three such projects, two COVID-19 assays and one non-COVID-19 assay, currently within this process. Subject to successful completion the Board expects that these will lead to meaningful manufacturing revenues in the next financial year.”
Is it us?
GLA
“Every second person getting tested in Kolkata is positive”
“Another reason for the high positivity is that only those who are symptomatic are going in for the tests,” said Bhaskar Narayan Chaudhuri, microbiologist at Peerless Hospital. ”
https://timesofindia.indiatimes.com/city/kolkata/every-second-person-getting-tested-in-kolkata-is-positive/articleshow/82236519.cms
“As part of the study the same clinical samples were tested with two leading, commercially available lateral flow antigen tests, and the data show that the AffiDx® test had better clinical sensitivity across the range of Ct value and in particular at lower viral loads.”
GLA
From the above list:
https://bidstats.uk/analysis/suppliers/malvern-medical-developments
This tweet (not mine) was not intended for us avct holders however it is so pertinent to us, it’s funny as are the responses.
GLA
https://twitter.com/ukshareman/status/1381188843349680128?s=21
Radiagreen, your post 7 56 am:
“Also, if the Affimer reagent is as good as we believe, I think it would make sense for DANAHER to require AVCT to keep quite regarding their development plans using Affimers.....”
Interesting my dyslexia changed “require” to acquire!
“Good companies get bought”
We seem to have lost a few very obvious ne’er do well’s from elsewhere but amongst us are those who would shed an element of doubt, to the well researched they are an irrelevance others would do very well to consider the Global market for the Affimer market, the UK I believe accounts for about .74 of world population.
GLA
On reading this morning’s rns and route to Global market with ABCAM I was reminded of this from the recent Business update (24/2/21)
“ Avacta is also in discussions with a large commercial partner to provide a route to market for the BAMS assay.”
GLA
L L P, no not me I’m still here though deep in my Freudian slumber awaiting a buyout, mind you how anyone could put a value on the Affimer platform let alone all the rest....
As you say:
GLA
“A gathering on Mother's Day has infected nine people with coronavirus and affected three school year groups, a local business and child and adult care settings.
Some of the people linked to the gathering are understood to have since been admitted to hospital.
The Welsh Government said that the nine people infected were from four separate households.”
https://www.walesonline.co.uk/news/wales-news/coronavirus-mothers-day-party-nine-20258923